These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 20728206)

  • 1. The effect of aspirin desensitization on novel biomarkers in aspirin-exacerbated respiratory diseases.
    Katial RK; Strand M; Prasertsuntarasai T; Leung R; Zheng W; Alam R
    J Allergy Clin Immunol; 2010 Oct; 126(4):738-44. PubMed ID: 20728206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The blocking effect of essential controller medications during aspirin challenges in patients with aspirin-exacerbated respiratory disease.
    White AA; Stevenson DD; Simon RA
    Ann Allergy Asthma Immunol; 2005 Oct; 95(4):330-5. PubMed ID: 16279562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selection of aspirin dosages for aspirin desensitization treatment in patients with aspirin-exacerbated respiratory disease.
    Lee JY; Simon RA; Stevenson DD
    J Allergy Clin Immunol; 2007 Jan; 119(1):157-64. PubMed ID: 17208597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early effects of aspirin desensitization treatment in asthmatic patients with aspirin-exacerbated respiratory disease.
    Berges-Gimeno MP; Simon RA; Stevenson DD
    Ann Allergy Asthma Immunol; 2003 Mar; 90(3):338-41. PubMed ID: 12669898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sputum biomarkers during aspirin desensitization in nonsteroidal anti-inflammatory drugs exacerbated respiratory disease.
    Tyrak KE; Kupryś-Lipińska I; Czarnobilska E; Jakieła B; Pajdzik K; Ćmiel A; Plutecka H; Koziej M; Gawrońska A; Konduracka E; Kuna P; Sanak M; Mastalerz L
    Respir Med; 2019 Jun; 152():51-59. PubMed ID: 31128610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of prolonged cyclooxygenase-2 inhibition on inflammatory markers and endothelial function in patients with ischemic heart disease and raised C-reactive protein: a randomized placebo-controlled study.
    Bogaty P; Brophy JM; Noel M; Boyer L; Simard S; Bertrand F; Dagenais GR
    Circulation; 2004 Aug; 110(8):934-9. PubMed ID: 15302800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Metalloproteinase-9/tissue inhibitor of metalloproteinase-1 in induced sputum in patients with asthma and chronic obstructive pulmonary disease and their relationship to airway inflammation and airflow limitation].
    Xin XF; Zhao M; Li ZL; Song Y; Shi Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Mar; 30(3):192-6. PubMed ID: 17572998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The natural history and clinical characteristics of aspirin-exacerbated respiratory disease.
    Berges-Gimeno MP; Simon RA; Stevenson DD
    Ann Allergy Asthma Immunol; 2002 Nov; 89(5):474-8. PubMed ID: 12452205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Failure of tacrolimus to prevent aspirin-induced respiratory reactions in patients with aspirin-exacerbated respiratory disease.
    Stevenson DD; Mehra PK; White AA; Gupta S; Woessner KM; Simon RA
    J Allergy Clin Immunol; 2005 Oct; 116(4):755-60. PubMed ID: 16210047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspirin challenge and desensitization for aspirin-exacerbated respiratory disease: a practice paper.
    Macy E; Bernstein JA; Castells MC; Gawchik SM; Lee TH; Settipane RA; Simon RA; Wald J; Woessner KM;
    Ann Allergy Asthma Immunol; 2007 Feb; 98(2):172-4. PubMed ID: 17304886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Allergy and intolerance to nonsteroidal antinflammatory drugs: successful desensitization in three cases].
    Cardona R; Ramírez RH; Reina Z; Escobar MF; Morales E
    Biomedica; 2009 Jun; 29(2):181-90. PubMed ID: 20128343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Aspirin sensitivity: long term follow-up after up to 3 years of adaptive desensitization using a maintenance dose of 100 mg of aspirin a day].
    Gosepath J; Schäfer D; Mann WJ
    Laryngorhinootologie; 2002 Oct; 81(10):732-8. PubMed ID: 12397524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspirin-exacerbated respiratory disease: update on pathogenesis and desensitization.
    White AA; Stevenson DD
    Semin Respir Crit Care Med; 2012 Dec; 33(6):588-94. PubMed ID: 23047310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspirin desensitization in aspirin-exacerbated respiratory disease.
    White AA; Stevenson DD
    Immunol Allergy Clin North Am; 2013 May; 33(2):211-22. PubMed ID: 23639709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspirin desensitization for patients with aspirin-exacerbated respiratory disease: A randomized double-blind placebo-controlled trial.
    Esmaeilzadeh H; Nabavi M; Aryan Z; Arshi S; Bemanian MH; Fallahpour M; Mortazavi N
    Clin Immunol; 2015 Oct; 160(2):349-57. PubMed ID: 26083948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An economic analysis of aspirin desensitization in aspirin-exacerbated respiratory disease.
    Shaker M; Lobb A; Jenkins P; O'Rourke D; Takemoto SK; Sheth S; Burroughs T; Dykewicz MS
    J Allergy Clin Immunol; 2008 Jan; 121(1):81-7. PubMed ID: 17716716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cromolyn sodium suppresses eosinophilic inflammation in patients with aspirin-intolerant asthma.
    Amayasu H; Nakabayashi M; Akahori K; Ishizaki Y; Shoji T; Nakagawa H; Hasegawa H; Yoshida S
    Ann Allergy Asthma Immunol; 2001 Aug; 87(2):146-50. PubMed ID: 11527248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aspirin desensitization in patients undergoing percutaneous coronary interventions with stent implantation.
    Rossini R; Angiolillo DJ; Musumeci G; Scuri P; Invernizzi P; Bass TA; Mihalcsik L; Gavazzi A
    Am J Cardiol; 2008 Mar; 101(6):786-9. PubMed ID: 18328841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rational approach to aspirin dosing during oral challenges and desensitization of patients with aspirin-exacerbated respiratory disease.
    Hope AP; Woessner KA; Simon RA; Stevenson DD
    J Allergy Clin Immunol; 2009 Feb; 123(2):406-10. PubMed ID: 19056109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of intranasal ketorolac and modified oral aspirin challenge for desensitization of aspirin-exacerbated respiratory disease.
    Lee RU; White AA; Ding D; Dursun AB; Woessner KM; Simon RA; Stevenson DD
    Ann Allergy Asthma Immunol; 2010 Aug; 105(2):130-5. PubMed ID: 20674823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.